J · K · L
Jennifer Kent, Lindsay Kenney
January 24, 2026
Latham & Watkins Advises Bio-Rad Laboratories in US$200 Million Credit Facility
1 min
AI-made summary
- Bio-Rad Laboratories, Inc
- has secured a revolving credit agreement of up to US$200 million, which includes up to US$25 million in letters of credit
- The funds will be used for acquisitions, working capital, and general corporate purposes
- Wells Fargo Bank, National Association serves as the administrative agent for a syndicate of lenders
- Latham & Watkins LLP represented Bio-Rad in the transaction, with a finance team led by partner Jennifer Kent and associate Lindsay Kenney.
Bio-Rad Laboratories, Inc. has entered into a credit agreement for up to US$200 million on a revolving basis, including up to US$25 million of letters of credit. Borrowings under the revolving credit agreement will be used to make acquisitions, for working capital and for other general corporate purposes. Wells Fargo Bank, National Association is the administrative agent under the facility for a syndicate of lenders. Latham & Watkins LLP represented Bio-Rad Laboratories, Inc. in the transaction with a finance team led by Washington, D.C. partner Jennifer Kent, with associate Lindsay Kenney.~~
J
Article Author
Jennifer Kent, Lindsay Kenney
The Sponsor
